ESG

A key investment in a massive French synthetic fuel plant aims to tackle aviation emissions, driven by EU mandates and advanced carbon capture technology.

A new university-industry partnership aims to solve the key challenges of orbital computing, validating early bets on the future of decentralized AI.

From Hong Kong to the world, Winson Siu's rigorous online teaching method is transforming student outcomes and building a multi-million dollar business.

Indian jeweler Aukera unveils its Extra Brilliant™ Solitaire, using light science and 2.5x more facets to challenge diamond industry traditions.

The oil producer's new BBB- ratings signal deep financial strength, unlocking lower borrowing costs, enhanced strategic options, and greater shareholder value.

At GTC 2026, LITEON unveils next-gen 800V power and cooling, a critical step to sustainably fuel the megawatt demands of NVIDIA's new AI supercomputers.

A new protocol aims to teach AI right from wrong before it even speaks. But can truth and morality truly be programmed? We investigate the promise and peril.

DNA Script's global expansion brings benchtop DNA printers to new markets, promising to accelerate research and decentralize biotech supply chains.

Grocery AI leader Afresh expands its platform from the fresh aisle to the entire store, promising to end system fragmentation and boost profits and sustainability.

With the home care market soaring, Compassus appoints Chris Core to scale its integrated services, leveraging a unique MSO model to expand its national reach.

Dave Asprey’s 2026 BEYOND conference adds star power and a focus on consciousness, but how much is science versus high-tech hype?

The deal, part of a broader consolidation strategy by parent The Lockwood Group, aims to meet rising pharma demand for advanced data and patient services.

A new Columbus program integrates trauma therapy and eating disorder care, offering a lifeline for patients with complex, interconnected conditions.

Moving beyond advice, Rain's new AI financial agent takes action to stabilize cash flow and build wealth, but it raises new questions about trust.

The FDA grants PolyPid a crucial $4.3 million fee waiver for its D-PLEX₁₀₀ drug, freeing up vital cash to accelerate its commercial launch.

One company is leveraging decades of manufacturing expertise to tackle the housing crisis with durable, trauma-informed furniture for community living.

A new partnership between LEOTEK, 1NCE, and SoftBank is set to accelerate the deployment of intelligent street lighting, transforming urban landscapes.

Mindgard's new platform automates attacker-style reconnaissance, aiming to secure AI models before exploits emerge in a rapidly evolving threat landscape.

A new injectable dye entering Phase 3 trials promises to make lung cancer cells glow, helping surgeons remove tumors more completely and prevent recurrence.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.